Concepedia

Venky Ramakrishna

VR

Statistics

Publications

12

Citations

1.1K

H-Index

11

Active since

1995

Affiliations

Celldex Therapeutics (United States)(Current)

Roswell Park Comprehensive Cancer Center

Carolina BioOncology Institute

Memorial Sloan Kettering Cancer Center

Dartmouth College

Venky Ramakrishna is an author at Celldex Therapeutics (United States) specializing in immunology, cancer immunotherapy, and cancer immunology.

Publications per year

1995–2017

12

Publications

12

Induction of Antigen-Specific Immunity with a Vaccine Targeting NY-ESO-1 to the Dendritic Cell Receptor DEC-205

Madhav V. Dhodapkar, Mario Sznol, Biwei Zhao et al. · Science Translational Medicine · 2014 · 357 citations

, , +10

Phase I Study Utilizing a Novel Antigen-Presenting Cell–Targeted Vaccine with Toll-like Receptor Stimulation to Induce Immunity to Self-antigens in Cancer Patients

Michael A. Morse, Robert Chapman, John D. Powderly et al. · Clinical Cancer Research · 2011 · 141 citations · Full text

, , +17

Antibody-Targeted NY-ESO-1 to Mannose Receptor or DEC-205 In Vitro Elicits Dual Human CD8+ and CD4+ T Cell Responses with Broad Antigen Specificity

Takemasa Tsuji, Junko Matsuzaki, Marcus P. Kelly et al. · The Journal of Immunology · 2010 · 117 citations · Full text

, , +17

Mannose Receptor Targeting of Tumor Antigen pmel17 to Human Dendritic Cells Directs Anti-Melanoma T Cell Responses via Multiple HLA Molecules

Venky Ramakrishna, Laura Vitale, John E. Connolly et al. · The Journal of Immunology · 2004 · 114 citations

, , +16

A Novel Human Cancer Vaccine Elicits Cellular Responses to the Tumor-Associated Antigen, Human Chorionic Gonadotropin β

Li-Zhen He, Venky Ramakrishna, John E. Connolly et al. · Clinical Cancer Research · 2004 · 67 citations · Full text

, , +17

1–5 of 12